rosiglitazone has been researched along with Friedreich Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acquaviva, F; Castaldo, I; Cocozza, S; Filla, A; Marmolino, D; Monticelli, A; Pinelli, M | 1 |
1 other study(ies) available for rosiglitazone and Friedreich Disease
Article | Year |
---|---|
PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy.
Topics: Cell Line, Tumor; Cells, Cultured; Cerebellum; Fibroblasts; Frataxin; Friedreich Ataxia; Humans; Hypoglycemic Agents; Iron-Binding Proteins; Phosphorylcholine; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcriptional Activation; Up-Regulation | 2009 |